News

Deal Announcements

Coronado Biosciences Raises New VC Funding

Friday, January 21, 2011 5:54:00 AM PDT | VentureDeal Staff
Seattle, Washington  --  Cancer biopharmaceutical company Coronado Biosciences has garnered $14 million in new venture capital investment, according to an SEC regulatory filing.

Coronado says that it is hoping to "make cancer care safer and more easily tolerated with improved outcomes."

According to the filing, the amount represented the value of certain shares of Coronado's preferred stock which were exchanged as consideration for the acquisition of certain assets.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1